XOMA Limited (NASDAQ:XOMA)
A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
NuclearSteve
(52.86)
Submitted: 4/12/2013 2:05:55 PM :
Start Price:
$3.46
XOMA Score:
+9.82
Baker brothers increased their holding.
Recs
usubanas
(99.48)
Submitted: 11/20/2012 11:49:34 PM :
Start Price:
$3.04
XOMA Score:
+13.25
Nov 7 CC: top line data from EYEGUARD-A study at the end of 2013.
I can wait a year.
Recs
Recs
RSue
(85.58)
Submitted: 4/28/2012 3:18:31 AM :
Start Price:
$2.48
XOMA Score:
+37.87
Quality scientific organization with deep pipeline in area of breakthrough novel antibody therapeutics under direction and leadership of deeply experienced Senior Vice-President of Research and Development/Chief Medical Officer Dr. Paul Rubin.
Recs
measured
(49.56)
Submitted: 4/24/2012 4:50:40 PM :
Start Price:
$2.85
XOMA Score:
+19.27
Need to have patience.A multibagger
Recs
TSIF
(99.96)
Submitted: 3/23/2012 11:03:14 AM :
Start Price:
$2.30
XOMA Score:
-54.45
Spiked 60% in early March (2012) despite $40 Million in Dilutive financing. Spike was caused because the new investors are noted hedge firms with good track records. New top/down management and refocus of drug trials may help this company, but a decade of attempts have not generated any meaningful results.
I don't know if the hedgies are right, or if changing the name of the drug will produce a different outcome, but I do know the Phase III trial results won't be out until the end of 2013, and while hte hedgies might be patient, most retail investors are not.
I expect some retrace as those who entered from the spike as wannabe's fade away.
Recs
zzlangerhans
(99.78)
Submitted: 3/7/2012 11:11:08 PM :
Start Price:
$1.89
XOMA Score:
-86.31
Investing in a Xoma, you know
You know, it's dubious
Investing in a Xoma, you know
You know, it's really dubious
There were times when I could have invested there
But you know, it was a good thing I didn't buy a share
No! Behcet's won't give cash flow!
Do you really think they'll pull through?
I don't really think they'll pull through
Investing in a Xoma, you know
You know, it's dubious
X,O,M,A,0,5,2 baby goodbye
There were times when I could have invested there
But you know, it was a good thing I didn't buy a share
Recs
jimscottage11
(< 20)
Submitted: 12/19/2011 7:00:59 AM :
Start Price:
$1.18
XOMA Score:
+199.65
New 52wk low on fri 16th 2011. could bounce
Recs
Recs
p1a5244
(83.76)
Submitted: 9/18/2011 11:20:44 PM :
Start Price:
$2.13
XOMA Score:
+47.10
9/18/11 Options Predictor Rank #33. P/C Ratio 0.075 and Call Sizzle 3.383.
Recs
rwpaules
(95.26)
Submitted: 6/20/2011 12:15:41 PM :
Start Price:
$2.30
XOMA Score:
-42.28
Poster child for R&D futility. Betting on them could be lucrative. Betting against them could be reasonable.
Recs
SCmaverick96
(22.67)
Submitted: 4/7/2011 8:33:29 PM :
Start Price:
$3.47
XOMA Score:
-9.79
I bought this stock around $5/share. Yes, I did take a huge blow from the bad research data about diabetes but I still believe I got a deal because cardiovascular is where it's at. I'm a nurse and that is what leads our nation in death tolls. The research is there, they just need to make it work. I know that's a big "IF" but I'm willing to hold on. I will buy more shares as soon as I can. I'm trying to keep my faith in the XOMA team to give that huge blockbuster drug so I can retire at 30.
Recs
hrairk
(< 20)
Submitted: 3/22/2011 10:25:16 PM :
Start Price:
$3.32
XOMA Score:
+9.42
Their "flagship" product just sank.
Recs
dangank
(< 20)
Submitted: 2/16/2011 10:30:29 AM :
Start Price:
$4.94
XOMA Score:
-43.68
The science seems to be sound, but one has the sense that no one, not even management really knows.
Recs
Recs
graniteguys
(48.18)
Submitted: 1/5/2011 2:27:05 PM :
Start Price:
$6.75
XOMA Score:
-71.50
Bought before reverse split
Hope make money back and little gain
Recs
dahabnick
(< 20)
Submitted: 12/28/2010 4:30:50 PM :
Start Price:
$4.82
XOMA Score:
-49.55
This is one of those single disease, solution focused companies. I believe diabetes is there game. Either they succeed or they don't. It will take time before there product can climb through the FDA approval jungle. Thats why Isay , at least 2 years. Anticipation until then will make it rise faster than others.
Recs
ferrarimondial32
(< 20)
Submitted: 12/28/2010 4:16:34 PM :
Start Price:
$4.82
XOMA Score:
-49.55
Blockbuster drug close to approval.
Recs
modestus1
(< 20)
Submitted: 12/28/2010 11:14:58 AM :
Start Price:
$4.88
XOMA Score:
-50.93
Drug sounds promising. Technical looks good.
Recs
blindsquirrel2
(< 20)
Submitted: 12/24/2010 1:00:07 AM :
Start Price:
$4.54
XOMA Score:
-44.84
OK I'm a sucker and have owned this company for 30 years, but the rumour is that their XOMA052 is going to finally be the blockbuster that makes this company
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 64 : 1 2 3 4 Next »